3229-2614 Screening compound: 2-[(2E)-2-[(4-{[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}-3-methoxyphenyl)methylidene]hydrazin-1-yl]-1,3-benzothiazole

3229-2614 Screening compound: 2-[(2E)-2-[(4-{[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}-3-methoxyphenyl)methylidene]hydrazin-1-yl]-1,3-benzothiazole
3229-2614 Screening compound: 2-[(2E)-2-[(4-{[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}-3-methoxyphenyl)methylidene]hydrazin-1-yl]-1,3-benzothiazole alternative view

Chemical Structure Depiction of ChemDiv screening compound 3229-2614
2-[(2E)-2-[(4-{[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}-3-methoxyphenyl)methylidene]hydrazin-1-yl]-1,3-benzothiazole

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3229-2614

Molecular Formula

C26H28N8O4S (C26 H28 N8 O4 S)

Compound Name

2-[(2E)-2-[(4-{[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]oxy}-3-methoxyphenyl)methylidene]hydrazin-1-yl]-1,3-benzothiazole

IUPAC name

2-[(2E)-2-[(4-{[46-bis(morpholin-4-yl)-135-triazin-2-yl]oxy}-3-methoxyphenyl)methylidene]hydrazin-1-yl]-13-benzothiazole

SMILES

COc(cc(/C=N/Nc1nc(cccc2)c2s1)cc1)c1Oc1nc(N2CCOCC2)nc(N2CCOCC2)n1

InChI

InChI=1S/C26H28N8O4S/c1-35-21-16-18(17-27-32-26-28-19-4-2-3-5-22(19)39-26)6-7-20(21)38-25-30-23(33-8-12-36-13-9-33)29-24(31-25)34-10-14-37-15-11-34/h2-7,16-17H,8-15H2,1H3,(H,28,32)

InChI Key

HSVXJVVVAXYIKU-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01963790

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

548.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

12

Partition Coefficient, logP

5.663

Distribution Coefficient, logD

5.659

Water Solubility, LogSw

-5.63

Polar Surface Area

95.845

Acid Dissociation Constant (pKa)

15.32

Base Dissociation Constant (pKb)

5.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

34.60

3229-2614 in Drug Discovery

Included in Screening Libraries

Akt-Targeted Library (14764 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 3229-2614 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3229-2614?
Check Price and Availability of 3229-2614, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3229-2614 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3229-2614
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3229-2614
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3229-2614 available by request